Regeneron Pharmaceuticals SG&A Expense (TTM) Trends

Regeneron Pharmaceuticals Inc (REGN)

980.59 +10.68 (+1.10%) USD | NASDAQ | May 31, 16:00

980.08 -0.51 (-0.05%) Pre-Market: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1992. Upgrade now.

Date	Value
March 31, 2024	2.719B
December 31, 2023	2.631B
September 30, 2023	2.554B
June 30, 2023	2.443B
March 31, 2023	2.267B
December 31, 2022	2.116B
September 30, 2022	2.015B
June 30, 2022	1.931B
March 31, 2022	1.869B
December 31, 2021	1.825B
September 30, 2021	1.569B
June 30, 2021	1.451B
March 31, 2021	1.384B
December 31, 2020	1.346B
September 30, 2020	1.494B
June 30, 2020	1.472B
March 31, 2020	1.418B
December 31, 2019	1.342B
September 30, 2019	952.40M
June 30, 2019	1.017B
March 31, 2019	1.087B
December 31, 2018	1.127B
September 30, 2018	1.475B
June 30, 2018	1.412B
March 31, 2018	1.354B

Date	Value
December 31, 2017	1.320B
September 30, 2017	1.236B
June 30, 2017	1.200B
March 31, 2017	1.185B
December 31, 2016	1.178B
September 30, 2016	1.147B
June 30, 2016	1.087B
March 31, 2016	969.21M
December 31, 2015	838.53M
September 30, 2015	718.88M
June 30, 2015	652.89M
March 31, 2015	575.03M
December 31, 2014	519.27M
September 30, 2014	443.02M
June 30, 2014	396.63M
March 31, 2014	372.36M
December 31, 2013	346.39M
September 30, 2013	305.07M
June 30, 2013	254.34M
March 31, 2013	229.59M
December 31, 2012	210.76M
September 30, 2012	189.36M
June 30, 2012	175.40M
March 31, 2012	152.28M
December 31, 2011	117.26M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

952.40M

Minimum

Sep 2019

2.719B

Maximum

Mar 2024

1.791B

Average

1.697B

Median

SG&A Expense (TTM) Benchmarks